Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 98

1.

Estimating progression to cirrhosis in chronic hepatitis C virus infection.

Freeman AJ, Dore GJ, Law MG, Thorpe M, Von Overbeck J, Lloyd AR, Marinos G, Kaldor JM.

Hepatology. 2001 Oct;34(4 Pt 1):809-16.

PMID:
11584380
2.

The risk of end stage liver disease and hepatocellular carcinoma among persons infected with hepatitis C virus: publication bias?

Goodgame B, Shaheen NJ, Galanko J, El-Serag HB.

Am J Gastroenterol. 2003 Nov;98(11):2535-42. Review.

PMID:
14638360
3.

Predicting progression to cirrhosis in chronic hepatitis C virus infection.

Freeman AJ, Law MG, Kaldor JM, Dore GJ.

J Viral Hepat. 2003 Jul;10(4):285-93. Review.

PMID:
12823595
4.

Effect of host-related factors on the intensity of liver fibrosis in patients with chronic hepatitis C virus infection.

Costa LB, Ferraz ML, Perez RM, Ferreira AS, Matos CA, Lanzoni VP, Silva AE.

Braz J Infect Dis. 2002 Oct;6(5):219-24.

PMID:
12495603
5.

Contribution of obesity to hepatitis C-related fibrosis progression.

Ortiz V, Berenguer M, Rayón JM, Carrasco D, Berenguer J.

Am J Gastroenterol. 2002 Sep;97(9):2408-14.

PMID:
12358265
6.

Rates and risk factors of liver fibrosis progression in patients with chronic hepatitis c.

Poynard T, Ratziu V, Charlotte F, Goodman Z, McHutchison J, Albrecht J.

J Hepatol. 2001 May;34(5):730-9.

PMID:
11434620
7.

Natural history of hepatitis C virus infection: from chronic hepatitis to cirrhosis, to hepatocellular carcinoma.

Leone N, Rizzetto M.

Minerva Gastroenterol Dietol. 2005 Mar;51(1):31-46. English, Italian.

PMID:
15756144
8.

Factors associated with the development of cirrhosis in patients with HCV chronic infection.

Dinis-Ribeiro M, Ramalho F, Glória H, Marinho R, Raimundo M, Serejo F, Velosa J, Carneiro-de-Moura M.

Hepatogastroenterology. 2005 Jan-Feb;52(61):176-9.

PMID:
15783023
9.

Natural course of chronic HCV and HBV infection and role of alcohol in the general population: the Dionysos Study.

Bedogni G, Miglioli L, Masutti F, Ferri S, Castiglione A, Lenzi M, Crocè LS, Granito A, Tiribelli C, Bellentani S.

Am J Gastroenterol. 2008 Sep;103(9):2248-53. doi: 10.1111/j.1572-0241.2008.01948.x. Epub 2008 Jul 12.

PMID:
18637095
10.

Natural history of hepatitis C virus infection.

Amarapurkar D.

J Gastroenterol Hepatol. 2000 May;15 Suppl:E105-10.

PMID:
10921391
11.

The rate of fibrosis progression is an independent predictor of the response to antiviral therapy in chronic hepatitis C.

Myers RP, Patel K, Pianko S, Poynard T, McHutchison JG.

J Viral Hepat. 2003 Jan;10(1):16-22.

PMID:
12558907
12.

Is severe liver disease a common outcome for people with chronic hepatitis C?

Dore GJ, Freeman AJ, Law M, Kaldor JM.

J Gastroenterol Hepatol. 2002 Apr;17(4):423-30. Review.

PMID:
11982723
13.

Natural history of hepatic fibrosis progression in chronic hepatitis C virus infection in India.

Hissar SS, Kumar M, Tyagi P, Goyal A, Suneetha PV, Agarwal S, Rastogi A, Sakhuja P, Sarin SK.

J Gastroenterol Hepatol. 2009 Apr;24(4):581-7. doi: 10.1111/j.1440-1746.2008.05649.x. Epub 2008 Nov 20.

PMID:
19032460
14.

The influence of human immunodeficiency virus coinfection on chronic hepatitis C in injection drug users: a long-term retrospective cohort study.

Di Martino V, Rufat P, Boyer N, Renard P, Degos F, Martinot-Peignoux M, Matheron S, Le Moing V, Vachon F, Degott C, Valla D, Marcellin P.

Hepatology. 2001 Dec;34(6):1193-9.

PMID:
11732009
15.

Factors associated with severity of hepatic fibrosis in people with chronic hepatitis C infection.

Danta M, Dore GJ, Hennessy L, Li Y, Vickers CR, Harley H, Ngu M, Reed W, Desmond PV, Sievert W, Farrell GC, Kaldor JM, Batey RG.

Med J Aust. 2002 Sep 2;177(5):240-5.

PMID:
12197817
16.

Estimation of stage-specific fibrosis progression rates in chronic hepatitis C virus infection: a meta-analysis and meta-regression.

Thein HH, Yi Q, Dore GJ, Krahn MD.

Hepatology. 2008 Aug;48(2):418-31. doi: 10.1002/hep.22375. Review.

PMID:
18563841
17.

Risk of developing specific AIDS-defining illnesses in patients coinfected with HIV and hepatitis C virus with or without liver cirrhosis.

d'Arminio Monforte A, Cozzi-Lepri A, Castagna A, Antinori A, De Luca A, Mussini C, Caputo SL, Arlotti M, Magnani G, Pellizzer G, Maggiolo F, Puoti M; Icona Foundation Study Group.

Clin Infect Dis. 2009 Aug 15;49(4):612-22. doi: 10.1086/603557.

PMID:
19591597
18.

A comparison of fibrosis progression in chronic liver diseases.

Poynard T, Mathurin P, Lai CL, Guyader D, Poupon R, Tainturier MH, Myers RP, Muntenau M, Ratziu V, Manns M, Vogel A, Capron F, Chedid A, Bedossa P; PANFIBROSIS Group.

J Hepatol. 2003 Mar;38(3):257-65.

PMID:
12586290
19.

Age at infection affects the long-term outcome of transfusion-associated chronic hepatitis C.

Minola E, Prati D, Suter F, Maggiolo F, Caprioli F, Sonzogni A, Fraquelli M, Paggi S, Conte D.

Blood. 2002 Jun 15;99(12):4588-91.

20.

Predictors of liver fibrosis in HIV-infected patients with chronic hepatitis C virus (HCV) infection: assessment using transient elastometry and the role of HCV genotype 3.

Barreiro P, Martín-Carbonero L, Núñez M, Rivas P, Morente A, Simarro N, Labarga P, González-Lahoz J, Soriano V.

Clin Infect Dis. 2006 Apr 1;42(7):1032-9. Epub 2006 Feb 21.

PMID:
16511772

Supplemental Content

Support Center